Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1988 Aug;51(8):1063–1068. doi: 10.1136/jnnp.51.8.1063

Anti-HIV antibodies in the CSF of AIDS patients: a serological and immunoblotting study.

K S Bukasa 1, C J Sindic 1, M Bodeus 1, G Burtonboy 1, C Laterre 1, J Sonnet 1
PMCID: PMC1033115  PMID: 3216207

Abstract

CSF and serum samples from 16 AIDS patients were tested for the presence of anti-HIV antibodies either by classical serological methods or by an immunoblot technique based on agarose gel isoelectric focusing and transfer of the specific IgG antibodies onto HIV antigens-loaded nitrocellulose sheets. This method enabled the demonstration of an intrathecal synthesis of anti-HIV oligoclonal IgG antibodies, often superimposed on diffuse polyclonal production, in 14 patients. The two negative cases were devoid of neurological signs or symptoms. However, two patients classified in stage II of the disease (asymptomatic infection) displayed an intrathecal synthesis of anti-HIV antibodies.

Full text

PDF
1063

Images in this article

1066Image
on p.1066
1067Image
on p.1067

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackermann R., Nekic M., Jürgens R. Locally synthesized antibodies in cerebrospinal fluid of patients with AIDS. J Neurol. 1986 Jun;233(3):140–141. doi: 10.1007/BF00314418. [DOI] [PubMed] [Google Scholar]
  2. Barré-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vézinet-Brun F., Rouzioux C. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983 May 20;220(4599):868–871. doi: 10.1126/science.6189183. [DOI] [PubMed] [Google Scholar]
  3. Boussin F., Dormont D., Merrouche Y., Fleury H., Dubeaux D., Bequet D., Goasguen J., Brunet P. Possible involvement of HIV in neuropsychiatric episode in patient seronegative for two (or more) years. Lancet. 1987 Sep 5;2(8558):571–572. doi: 10.1016/s0140-6736(87)92957-6. [DOI] [PubMed] [Google Scholar]
  4. Carne C. A., Tedder R. S., Smith A., Sutherland S., Elkington S. G., Daly H. M., Preston F. E., Craske J. Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet. 1985 Nov 30;2(8466):1206–1208. doi: 10.1016/s0140-6736(85)90740-8. [DOI] [PubMed] [Google Scholar]
  5. Chermann J. C., Barré-Sinoussi F., Dauguet C., Brun-Vezinet F., Rouzioux C., Rozenbaum W., Montagnier L. Isolation of a new retrovirus in a patient at risk for acquired immunodeficiency syndrome. Antibiot Chemother (1971) 1983;32:48–53. doi: 10.1159/000409704. [DOI] [PubMed] [Google Scholar]
  6. Dörries R., Ter Meulen V. Detection and identification of virus-specific, oligoclonal IgG in unconcentrated cerebrospinal fluid by immunoblot technique. J Neuroimmunol. 1984 Dec;7(2-3):77–89. doi: 10.1016/s0165-5728(84)80008-9. [DOI] [PubMed] [Google Scholar]
  7. Elovaara I., Iivanainen M., Valle S. L., Suni J., Tervo T., Lähdevirta J. CSF protein and cellular profiles in various stages of HIV infection related to neurological manifestations. J Neurol Sci. 1987 May;78(3):331–342. doi: 10.1016/0022-510x(87)90046-3. [DOI] [PubMed] [Google Scholar]
  8. Goudsmit J., Wolters E. C., Bakker M., Smit L., Van der Noordaa J., Hische E. A., Tutuarima J. A., Van der Helm H. J. Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex. Br Med J (Clin Res Ed) 1986 May 10;292(6530):1231–1234. doi: 10.1136/bmj.292.6530.1231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ho D. D., Rota T. R., Schooley R. T., Kaplan J. C., Allan J. D., Groopman J. E., Resnick L., Felsenstein D., Andrews C. A., Hirsch M. S. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med. 1985 Dec 12;313(24):1493–1497. doi: 10.1056/NEJM198512123132401. [DOI] [PubMed] [Google Scholar]
  10. Hollander H., Levy J. A. Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid. Ann Intern Med. 1987 May;106(5):692–695. doi: 10.7326/0003-4819-106-5-692. [DOI] [PubMed] [Google Scholar]
  11. Leport C., Chaunu M. P., Sicre J., Brun-Vezinet F., Hauw J. J., Vildé J. L. Neuropathie périphérique en relation avec l'infection par le rétrovirus LAV/HTLV III. Etude clinique, anatomique et immunologique. Cinq observations. Presse Med. 1987 Jan 24;16(2):55–58. [PubMed] [Google Scholar]
  12. Levy R. M., Bredesen D. E., Rosenblum M. L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg. 1985 Apr;62(4):475–495. doi: 10.3171/jns.1985.62.4.0475. [DOI] [PubMed] [Google Scholar]
  13. Martínez-Maza O., Crabb E., Mitsuyasu R. T., Fahey J. L., Giorgi J. V. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol. 1987 Jun 1;138(11):3720–3724. [PubMed] [Google Scholar]
  14. Navia B. A., Jordan B. D., Price R. W. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986 Jun;19(6):517–524. doi: 10.1002/ana.410190602. [DOI] [PubMed] [Google Scholar]
  15. Papadopoulos N. M., Lane H. C., Costello R., Moutsopoulos H. M., Masur H., Gelmann E. P., Fauci A. S. Oligoclonal immunoglobulins in patients with the acquired immunodeficiency syndrome. Clin Immunol Immunopathol. 1985 Apr;35(1):43–46. doi: 10.1016/0090-1229(85)90076-5. [DOI] [PubMed] [Google Scholar]
  16. Petito C. K., Navia B. A., Cho E. S., Jordan B. D., George D. C., Price R. W. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1985 Apr 4;312(14):874–879. doi: 10.1056/NEJM198504043121402. [DOI] [PubMed] [Google Scholar]
  17. Piette A. M., Tusseau F., Chapman A. Symptomatologie aiguë contemporaine de la primo-infection par le virus HIV. Deux observations. Presse Med. 1987 Feb 28;16(7):346–348. [PubMed] [Google Scholar]
  18. Resnick L., diMarzo-Veronese F., Schüpbach J., Tourtellotte W. W., Ho D. D., Müller F., Shapshak P., Vogt M., Groopman J. E., Markham P. D. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med. 1985 Dec 12;313(24):1498–1504. doi: 10.1056/NEJM198512123132402. [DOI] [PubMed] [Google Scholar]
  19. Sharer L. R., Epstein L. G., Cho E. S., Joshi V. V., Meyenhofer M. F., Rankin L. F., Petito C. K. Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain. Hum Pathol. 1986 Mar;17(3):271–284. doi: 10.1016/s0046-8177(83)80220-2. [DOI] [PubMed] [Google Scholar]
  20. Shaw G. M., Harper M. E., Hahn B. H., Epstein L. G., Gajdusek D. C., Price R. W., Navia B. A., Petito C. K., O'Hara C. J., Groopman J. E. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science. 1985 Jan 11;227(4683):177–182. doi: 10.1126/science.2981429. [DOI] [PubMed] [Google Scholar]
  21. Snider W. D., Simpson D. M., Nielsen S., Gold J. W., Metroka C. E., Posner J. B. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol. 1983 Oct;14(4):403–418. doi: 10.1002/ana.410140404. [DOI] [PubMed] [Google Scholar]
  22. Tourtellotte W. W., Potvin A. R., Fleming J. O., Murthy K. N., Levy J., Syndulko K., Potvin J. H. Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology. 1980 Mar;30(3):240–244. doi: 10.1212/wnl.30.3.240. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES